Recursion Pharmaceuticals Inc. (RXRX.MX) at a glance

Recursion Pharmaceuticals Inc. (RXRX.MX) is a large-cap Healthcare company. It trades at $57.19, with a 4.4% profit margin and revenue decline of 56.1%. It does not pay a dividend. Vestovix scores it 36/100 overall. Its strongest dimension is Value (53/100) and its weakest is Growth (11/100). Its volatility is roughly in line with the market.

Price

MX$57.19

Market cap

$28.13B

P/E ratio

n/a

Dividend yield

None

Beta

0.99

52-week range

MX$49.00 to MX$121.50